Axel Knoch

Title: Axel Knoch: Innovator in Transdermal Therapeutics

Introduction

Axel Knoch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal therapeutic systems. With a total of 2 patents, Knoch's work focuses on innovative methods for drug delivery.

Latest Patents

One of Knoch's latest patents is a transdermal therapeutic system that utilizes physostigmine as an active component. This invention involves a system designed for the administration of physostigmine through a backing layer that is impermeable to active substances. The system includes an active substance deposit with auxiliary agents in the form of textile fabric material, surrounded by a matrix that comprises a specific percentage of polymeric materials. Another significant patent is a sprayable pharmaceutical composition for topical use, which contains arylalkanoic acid or its salts as the active agent. This composition is particularly effective for treating traumatic and rheumatic diseases.

Career Highlights

Throughout his career, Axel Knoch has worked with reputable companies such as Klinge Pharma GmbH and LTS Lohmann Therapie-Systeme GmbH & Co. KG. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Knoch has collaborated with notable professionals in the field, including Friedrich Stanislaus and Josef M. Hofer. These collaborations have further enhanced his contributions to pharmaceutical research and development.

Conclusion

Axel Knoch's innovative work in transdermal therapeutics showcases his commitment to advancing pharmaceutical technology. His patents reflect a deep understanding of drug delivery systems, making him a significant figure in the industry.